Athersys Inc ATHX:NASDAQ

Last Price$0.82NASDAQ Previous Close - Last Trade as of 3:57PM ET 1/26/22

Today's Change+0.005(0.60%)
Bid (Size)$0.76 (60)
Ask (Size)$0.93 (1)
Day Low / High$0.81 - 0.87
Volume1.2 M
 

View Biotechnology IndustryPeer Comparison as of 01/26/2022

 

Athersys Inc ( NASDAQ )

Price: $0.82
Change: +0.005 (0.60%)
Volume: 1.2 M
3:57PM ET 1/26/2022
 
 

9 Meters Biopharma Inc ( NASDAQ )

Price: $0.75
Change: +0.005 (0.63%)
Volume: 986.6 K
3:57PM ET 1/26/2022
 
 

ZIOPHARM Oncology Inc ( NASDAQ )

Price: $0.87
Change: -0.008 (0.88%)
Volume: 2.1 M
3:57PM ET 1/26/2022
 
 

Homology Medicines Inc ( NASDAQ )

Price: $3.36
Change: -0.11 (3.17%)
Volume: 439.3 K
3:57PM ET 1/26/2022
 
 

Paratek Pharmaceuticals Inc ( NASDAQ )

Price: $3.77
Change: -0.19 (4.80%)
Volume: 737.2 K
3:57PM ET 1/26/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Decline Pre-Bell Friday
9:17AM ET 1/21/2022 MT Newswires

Health care stocks were declining pre-bell Friday. The Health Care SPDR (XLV) was down 0.11% and the iShares NASDAQ Biotechnology Index (IBB) was recently...

Athersys Appoints Chief Executive Officer
3:19AM ET 1/21/2022 MT Newswires

Athersys (ATHX) said Thursday that Daniel Camardo has been named chief executive officer, effective Feb. 14. Camardo will also join the company's board of...

--BofA Securities Downgrades Athersys to Neutral From Buy; Price Target is $1.25
10:03AM ET 11/19/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (ATHX) ATHERSYS Reports Q3 Revenue $4.8M
4:08PM ET 11/15/2021 MT Newswires

...

Company Profile

Business DescriptionAthersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. View company web site for more details
Address3201 Carnegie Avenue
Cleveland, Ohio 44115-2634
Phone+1.216.431.9900
Number of Employees75
Recent SEC Filing01/21/20228-K
President, Chief Executive & Operating OfficerWilliam B. J. Lehmann
Chief Financial & Accounting OfficerIvor MacLeod
Director, Chief Scientific Officer & Executive VPJohn J. Harrington
Head-Information Technology & CommunicationsRakesh Ramachandran

Company Highlights

Price Open$0.82
Previous Close$0.82
52 Week Range$0.75 - 3.03
Market Capitalization$193.1 M
Shares Outstanding235.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.41
Beta vs. S&P 500N/A
Revenue$24.3 M
Net Profit Margin-1,442.59%
Return on Equity-268.18%

Analyst Ratings as of 11/18/2021

Buy
3
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset